Letter From The Editor

We have spent the better part of the last two months delving deep into the subject of Glucose metabolism in our Clinical Text. As we come to nearly the close of the author’s focus on Glycolysis, take a look to see how there may be new targets for diabetes and …

Diabetes research can be a very fickle world at times. Over the years we have heard of many “cures” for type 1 diabetes. Most of the time the discoverer is someone not well known in the diabetes community and the work is dismissed as pie in the sky. This kind …

We all make the assumption that insulin resistance comes from eating too much glucose. However, for many patients, this resistance occurs because they release too much insulin. This can be environmentally related or it can be blamed on heredity. Regardless of the cause, this hyperinsulinemia can result in long-lasting effects …

The first line therapy for type 2 diabetes has long been metformin, and nowadays we are using it for patents who have prediabetes; it is also used “unofficially” by a lot of Weight Loss clinics. A lot of patients who are on metformin progress to insulin, and for many years …

We all know of patients who walk around with glucose levels of 400mg/dl without any problems functioning. Most of our patients are often 100-200 points too high and they don’t even know it. When we start them on insulin, we usually go slow for fear of hypoglycemia, as often it …

For many years, we never really gave great concern to the micro- and macrovascular problems in type 2 patients. Most of them were not diagnosed until they were in their late 50’s or early 60’s, and they did not really live long enough to develop severe problems. Now that diabetes …

I recently spent some time talking to the director of one of the transplant centers in Florida that specializes in liver and kidney transplants. She was explaining all the the factors that go into finding a correct match for patients, how patients who need a kidney are selected and how …

This week, the AMA, in their journal, advised that they were in discussions to shift their focus from A1c and glucose readings as an indicator of successful diabetes management to a more cardiovascular outcomes and mortality data measurement of success. I am in total agreement that improving these numbers will …

I got to the office in Atlanta after a week at home and it looked like the sidewalks have been coated with yellow paint. But it was pollen from all the trees. Evidently the rapid changes in temperature over the past month or so had driven the pollen factor into …

About 6-7 years ago, Dr. Oz came on TV touting the benefit of reservatrol for weight loss, and overnight sales went through the roof. He had his own brand and pretty soon every nutritional company had their product on the market. Just like every nutritional product, it worked for motivated …